메뉴 건너뛰기




Volumn 9, Issue 2, 2009, Pages 157-170

Premenstrual syndrome and premenstrual dysphoric disorder: Quality of life and burden of illness

Author keywords

Burden of illness; Premenstrual dysphoric disorder; Premenstrual syndrome; Quality of life

Indexed keywords

CALCIUM; DROSPIRENONE; ESTROGEN; ETHINYLESTRADIOL; FLUOXETINE; GONADORELIN ANTAGONIST; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PLACEBO; PROGESTERONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

EID: 68349161331     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.09.14     Document Type: Review
Times cited : (150)

References (76)
  • 2
    • 0042345004 scopus 로고    scopus 로고
    • Health and economic impact of the premenstrual syndrome
    • Borenstein JE, Dean BB, Endicott J et al. Health and economic impact of the premenstrual syndrome. J. Report. Med. 48(7), 515-524 (2003).
    • (2003) J. Report. Med , vol.48 , Issue.7 , pp. 515-524
    • Borenstein, J.E.1    Dean, B.B.2    Endicott, J.3
  • 3
    • 0038406087 scopus 로고    scopus 로고
    • Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment
    • Pearlstein T, Joliat MJ, Brown EB, Miner CM. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. Am. J. Obstet. Gynecol. 188, 887-895 (2003).
    • (2003) Am. J. Obstet. Gynecol , vol.188 , pp. 887-895
    • Pearlstein, T.1    Joliat, M.J.2    Brown, E.B.3    Miner, C.M.4
  • 4
    • 0036271001 scopus 로고    scopus 로고
    • Severity of premenstrual symptoms in a health maintenance organization population
    • Sternfeld B, Swindle R, Chawla A, Long S. Severity of premenstrual symptoms in a health maintenance organization population. Obstet. Gynecol. 99(6), 1014-1024 (2002).
    • (2002) Obstet. Gynecol , vol.99 , Issue.6 , pp. 1014-1024
    • Sternfeld, B.1    Swindle, R.2    Chawla, A.3    Long, S.4
  • 5
    • 0024788859 scopus 로고
    • Depressive episodes in premenstrual syndrome
    • Mortola JF, Girton L, Yen SS. Depressive episodes in premenstrual syndrome. Am. J. Obstet. Gynecol. 161(6, Pt 1), 1682-1687 (1989).
    • (1989) Am. J. Obstet. Gynecol , vol.161 , Issue.6 and PART 1 , pp. 1682-1687
    • Mortola, J.F.1    Girton, L.2    Yen, S.S.3
  • 6
    • 0005946141 scopus 로고    scopus 로고
    • Premenstrual syndrome
    • American College of Obstetricians and Gynecologists
    • American College of Obstetricians and Gynecologists. Premenstrual syndrome. ACOG Pract. Bull. 15, 1-9 (2000).
    • (2000) ACOG Pract. Bull , vol.15 , pp. 1-9
  • 9
    • 0242482637 scopus 로고    scopus 로고
    • The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/ PMDD)
    • Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/ PMDD). Psychoneuroendocrinology Suppl. 3, 1-23 (2003).
    • (2003) Psychoneuroendocrinology Suppl , vol.3 , pp. 1-23
    • Halbreich, U.1    Borenstein, J.2    Pearlstein, T.3    Kahn, L.S.4
  • 11
    • 33645383081 scopus 로고    scopus 로고
    • Premenstrual syndrome in adolescents: Diagnosis and treatment
    • Rapkin AJ, Mikacich JA. Premenstrual syndrome in adolescents: diagnosis and treatment. Pediatr. Endocrinol. Rev. 3(Suppl. 1), 132-137 (2006),
    • (2006) Pediatr. Endocrinol. Rev , vol.3 , Issue.SUPPL. 1 , pp. 132-137
    • Rapkin, A.J.1    Mikacich, J.A.2
  • 12
    • 0642311952 scopus 로고    scopus 로고
    • Premenstrual syndrome and premenstrual dysphoric disorder: Definitions and diagnosis
    • Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 28(Suppl. 3), 25-37 (2003).
    • (2003) Psychoneuroendocrinology , vol.28 , Issue.SUPPL. 3 , pp. 25-37
    • Freeman, E.W.1
  • 13
    • 0038246106 scopus 로고    scopus 로고
    • The etiology, biology, and evolving pathology of premenstrual syndromes
    • Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 28(Suppl. 3), 55-99 (2003).
    • (2003) Psychoneuroendocrinology , vol.28 , Issue.SUPPL. 3 , pp. 55-99
    • Halbreich, U.1
  • 14
    • 0023483493 scopus 로고
    • Genetic and environmental variation in menstrual cycle: Histories of two British twin samples
    • Van der Akker OBA et al. Genetic and environmental variation in menstrual cycle: histories of two British twin samples. Acta Genet. Med. Gemellol. (Roma) 36, 541-548 (1987).
    • (1987) Acta Genet. Med. Gemellol. (Roma) , vol.36 , pp. 541-548
    • Van der Akker, O.B.A.1
  • 15
    • 0026576953 scopus 로고
    • Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: A population-based twin study
    • Kendler KS et al. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol. Med. 22, 85-100 (1992).
    • (1992) Psychol. Med , vol.22 , pp. 85-100
    • Kendler, K.S.1
  • 16
    • 0025776112 scopus 로고
    • The relationship between perimenstrual depressive mood and depressive illness
    • Warner P. The relationship between perimenstrual depressive mood and depressive illness. J. Affect. Disord. 23, 9-23 (1991).
    • (1991) J. Affect. Disord , vol.23 , pp. 9-23
    • Warner, P.1
  • 17
    • 0027514990 scopus 로고
    • The menstrual cycle and mood disorders
    • Endicott J: The menstrual cycle and mood disorders. J. Affect. Disord. 29(2-3), 193-200 (1993).
    • (1993) J. Affect. Disord , vol.29 , Issue.2-3 , pp. 193-200
    • Endicott, J.1
  • 18
    • 0023193169 scopus 로고
    • Whole-blood serotonin in premenstrual syndrome
    • Rapkin AJ, Edelmuth E, Chang LC et al. Whole-blood serotonin in premenstrual syndrome. Obstet. Gynecol. 70(4), 533-537 (1987).
    • (1987) Obstet. Gynecol , vol.70 , Issue.4 , pp. 533-537
    • Rapkin, A.J.1    Edelmuth, E.2    Chang, L.C.3
  • 19
    • 30644474376 scopus 로고    scopus 로고
    • Exploratory study of premenstrual symptoms and serotonin variability. Arch Womens Ment
    • Clayton AH, Keller AE, Leslie C et al. Exploratory study of premenstrual symptoms and serotonin variability. Arch Womens Ment. Health 9(1), 51-57 (2006).
    • (2006) Health , vol.9 , Issue.1 , pp. 51-57
    • Clayton, A.H.1    Keller, A.E.2    Leslie, C.3
  • 20
    • 0033971503 scopus 로고    scopus 로고
    • Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome
    • Rasgon N, Mcguire M, Tanavoli S et al. Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Fertil. Steril. 73(1), 144-149 (2000).
    • (2000) Fertil. Steril , vol.73 , Issue.1 , pp. 144-149
    • Rasgon, N.1    Mcguire, M.2    Tanavoli, S.3
  • 21
    • 0034922239 scopus 로고    scopus 로고
    • Neuroactive steroid-serotonergic interaction: Responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome
    • 14525-14533
    • Rasgon N, Serra M, Biggio G et al. Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Eur. J. Endocrinol. 14525-14533 (2001).
    • (2001) Eur. J. Endocrinol
    • Rasgon, N.1    Serra, M.2    Biggio, G.3
  • 22
    • 33750966749 scopus 로고    scopus 로고
    • A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria
    • Jovanovic H, Cerin A, Karlsson P et al. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res. 148(2-3), 185-193 (2006).
    • (2006) Psychiatry Res , vol.148 , Issue.2-3 , pp. 185-193
    • Jovanovic, H.1    Cerin, A.2    Karlsson, P.3
  • 23
    • 69849083027 scopus 로고    scopus 로고
    • Wyatt KM, Dimmock PW, O'Brien PM. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst. Rev. 4, CD001396 (2002).
    • Wyatt KM, Dimmock PW, O'Brien PM. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst. Rev. 4, CD001396 (2002).
  • 24
    • 0032851143 scopus 로고    scopus 로고
    • Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial
    • Freeman EW, Rickets K, Sondheimer SJ et al. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch. Gen. Psychiatry 56(10), 932-939 (1999).
    • (1999) Arch. Gen. Psychiatry , vol.56 , Issue.10 , pp. 932-939
    • Freeman, E.W.1    Rickets, K.2    Sondheimer, S.J.3
  • 25
    • 10744221911 scopus 로고    scopus 로고
    • Pathogenesis in menstrual cycle-linked disorders
    • Backstrom T, Andersson A, Andree L et al. Pathogenesis in menstrual cycle-linked disorders. Ann. NY Acad. Sci. 1007, 42-53 (2003).
    • (2003) Ann. NY Acad. Sci , vol.1007 , pp. 42-53
    • Backstrom, T.1    Andersson, A.2    Andree, L.3
  • 26
    • 0032556992 scopus 로고    scopus 로고
    • Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome
    • Schmidt PJ, Nieman LK, Danaceau MA et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 338(4), 256-257 (1998).
    • (1998) N. Engl. J. Med , vol.338 , Issue.4 , pp. 256-257
    • Schmidt, P.J.1    Nieman, L.K.2    Danaceau, M.A.3
  • 27
    • 0022483382 scopus 로고
    • Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
    • Majewska MD, Harrison NL, Schwartz RD et al. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232(4753), 1004-1007 (1986).
    • (1986) Science , vol.232 , Issue.4753 , pp. 1004-1007
    • Majewska, M.D.1    Harrison, N.L.2    Schwartz, R.D.3
  • 28
    • 0030762277 scopus 로고    scopus 로고
    • Progesterone metabolite allopregnanolone in women with premenstrual syndrome
    • Rapkin Aj, Morgan M, Goldman L et al. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet. Gynecol. 90(5), 709-714 (1997).
    • (1997) Obstet. Gynecol , vol.90 , Issue.5 , pp. 709-714
    • Rapkin, A.1    Morgan, M.2    Goldman, L.3
  • 29
    • 0029961691 scopus 로고    scopus 로고
    • Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5 α-pregnane-3,20-dione and 3 α-hydroxy-5 α-pregnan-20-one
    • Wang M, Seippel L, Purdy RH, Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 α-pregnane-3,20-dione and 3 α-hydroxy-5 α-pregnan-20-one. J. Clin. Endocrinol. Metab. 81(3), 1076-1082 (1996).
    • (1996) J. Clin. Endocrinol. Metab , vol.81 , Issue.3 , pp. 1076-1082
    • Wang, M.1    Seippel, L.2    Purdy, R.H.3    Bäckström, T.4
  • 30
    • 0028037297 scopus 로고
    • Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects
    • Schmidt PJ, Purdy RH, Moore PH Jr et al. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J. Clin. Endocrinol. Metab. 79(5), 1256-1260 (1994).
    • (1994) J. Clin. Endocrinol. Metab , vol.79 , Issue.5 , pp. 1256-1260
    • Schmidt, P.J.1    Purdy, R.H.2    Moore Jr, P.H.3
  • 31
    • 0036231790 scopus 로고    scopus 로고
    • A receptor gene regulation in the brain and anxiety behavior
    • A receptor gene regulation in the brain and anxiety behavior. Steroids 67(6), 519-528 (2002).
    • (2002) Steroids , vol.67 , Issue.6 , pp. 519-528
    • Smith, S.S.1
  • 33
    • 34547811620 scopus 로고    scopus 로고
    • Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder
    • Thys-Jacobs S, McMahon D, Bilesikian JP. Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder. J Clin. Endocrinol. Metab. 92(8), 2952-2959 (2007).
    • (2007) J Clin. Endocrinol. Metab , vol.92 , Issue.8 , pp. 2952-2959
    • Thys-Jacobs, S.1    McMahon, D.2    Bilesikian, J.P.3
  • 34
    • 0034734709 scopus 로고    scopus 로고
    • Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
    • Dimmock PW, Wyatt KM, Jones PW et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356, 1131-1136 (2000).
    • (2000) Lancet , vol.356 , pp. 1131-1136
    • Dimmock, P.W.1    Wyatt, K.M.2    Jones, P.W.3
  • 35
    • 23844502550 scopus 로고    scopus 로고
    • Lueal phase dosing with paroxetine controlled release (Cr) in the treatment of premenstrual dyshoric disorder
    • Steiner M, Hirshberg AL, Bergeron R et al. Lueal phase dosing with paroxetine controlled release (Cr) in the treatment of premenstrual dyshoric disorder. Am. J Obstet. Gynecol. 193(2), 352-360 (2005).
    • (2005) Am. J Obstet. Gynecol , vol.193 , Issue.2 , pp. 352-360
    • Steiner, M.1    Hirshberg, A.L.2    Bergeron, R.3
  • 36
    • 0036709923 scopus 로고    scopus 로고
    • Premenstrual daily fluoxetine for premenstrual dysphoric disorder: A placebo-controlled, clinical trial using computerized diaries
    • Cohen LS, Miner C, Brown EW et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet. Gynecol. 100(3), 435-444 (2002).
    • (2002) Obstet. Gynecol , vol.100 , Issue.3 , pp. 435-444
    • Cohen, L.S.1    Miner, C.2    Brown, E.W.3
  • 37
    • 0030759158 scopus 로고    scopus 로고
    • Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome
    • Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J. Clin. Psychiatry 58(9), 399-402 (1997).
    • (1997) J. Clin. Psychiatry , vol.58 , Issue.9 , pp. 399-402
    • Halbreich, U.1    Smoller, J.W.2
  • 38
    • 0034534382 scopus 로고    scopus 로고
    • Compliance to antidepressant drug therapy for treatment of premenstrual syndrome
    • Sundström-Poromaa I, Bixo M, Björn I et al. Compliance to antidepressant drug therapy for treatment of premenstrual syndrome. J. Psychosom. Obstet. Gynaecol. 21(4), 205-211 (2000).
    • (2000) J. Psychosom. Obstet. Gynaecol , vol.21 , Issue.4 , pp. 205-211
    • Sundström-Poromaa, I.1    Bixo, M.2    Björn, I.3
  • 39
    • 0036384236 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: The emerging gold standard?
    • Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard? Drugs 62 (13), 1869-1885 (2002).
    • (2002) Drugs , vol.62 , Issue.13 , pp. 1869-1885
    • Pearlstein, T.1
  • 40
    • 0028145381 scopus 로고
    • Long-term fluoxetine treatment of late luteal phase dysphoric disorder
    • Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J. Clin. Psychiatry. 55, 332-335 (1994).
    • (1994) J. Clin. Psychiatry , vol.55 , pp. 332-335
    • Pearlstein, T.B.1    Stone, A.B.2
  • 41
    • 42949168966 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. a meta-analysis
    • Shah NR, Jones JB, Aperi J et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. a meta-analysis. Obstet. Gynecol. 111(5), 1175-1182 (2008).
    • (2008) Obstet. Gynecol , vol.111 , Issue.5 , pp. 1175-1182
    • Shah, N.R.1    Jones, J.B.2    Aperi, J.3
  • 42
    • 0347357748 scopus 로고    scopus 로고
    • Impact of oral contraceptive pill use on premenstrual mood: Predictors of improvement and deterioration
    • Joffe H, Cohen LS, Harlow BL. Impact of oral contraceptive pill use on premenstrual mood: Predictors of improvement and deterioration. Am. J. Obstet. Gynecol. 189(6), 1523-1530 (2003).
    • (2003) Am. J. Obstet. Gynecol , vol.189 , Issue.6 , pp. 1523-1530
    • Joffe, H.1    Cohen, L.S.2    Harlow, B.L.3
  • 43
    • 0033168809 scopus 로고    scopus 로고
    • Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity
    • Sullivan H, Furniss H, Spona J et al. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertil. Steril. 72(1), 115-120 (1999).
    • (1999) Fertil. Steril , vol.72 , Issue.1 , pp. 115-120
    • Sullivan, H.1    Furniss, H.2    Spona, J.3
  • 45
    • 0028910917 scopus 로고
    • Drospirenone: A novel progestogen with antimineralcorticoid and antiandrogenic activity. Pharmacological characterization in animal models
    • Muhn P, Krattemacher R, Beier S et al. Drospirenone: a novel progestogen with antimineralcorticoid and antiandrogenic activity. Pharmacological characterization in animal models. Contraception 51(2), 99-110 (1995).
    • (1995) Contraception , vol.51 , Issue.2 , pp. 99-110
    • Muhn, P.1    Krattemacher, R.2    Beier, S.3
  • 46
    • 0033954689 scopus 로고    scopus 로고
    • Hormonal withdrawal symptoms in oral contraceptive users
    • Sulak PJ, Scow RD, Preece C. Hormonal withdrawal symptoms in oral contraceptive users. Obstet. Gynecol. 95(2), 261-266 (2000).
    • (2000) Obstet. Gynecol , vol.95 , Issue.2 , pp. 261-266
    • Sulak, P.J.1    Scow, R.D.2    Preece, C.3
  • 47
    • 23944510662 scopus 로고    scopus 로고
    • Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder
    • Yonkers KA, Brown C, Pearlstein TB et al. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet. Gynecol. 106(3), 492-501 (2005).
    • (2005) Obstet. Gynecol , vol.106 , Issue.3 , pp. 492-501
    • Yonkers, K.A.1    Brown, C.2    Pearlstein, T.B.3
  • 48
    • 27944495205 scopus 로고    scopus 로고
    • Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation
    • Pearlstein TB, Bachmann GA, Zacur HA et al. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 72(6), 414-421 (2005).
    • (2005) Contraception , vol.72 , Issue.6 , pp. 414-421
    • Pearlstein, T.B.1    Bachmann, G.A.2    Zacur, H.A.3
  • 49
    • 34047154390 scopus 로고    scopus 로고
    • Westhoff CL, Heartwell S, Edwards S et al. Oral contraceptive discontinuation: do side effects matter? Am. J. Obstet. Gynecol. 196(4), 412-416; discussion 412. e6 (2007).
    • Westhoff CL, Heartwell S, Edwards S et al. Oral contraceptive discontinuation: do side effects matter? Am. J. Obstet. Gynecol. 196(4), 412-416; discussion 412. e6 (2007).
  • 50
    • 0025729905 scopus 로고
    • Successful treatment of severe premenstrual syndrome by combined use of gonadotrophin-releasing hormone agonist and estrogen/progestin
    • Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotrophin-releasing hormone agonist and estrogen/progestin. J. Clin. Endocrinol. Metab. 71, 252A-252F (1991).
    • (1991) J. Clin. Endocrinol. Metab , vol.71
    • Mortola, J.F.1    Girton, L.2    Fischer, U.3
  • 51
    • 2942512800 scopus 로고    scopus 로고
    • The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: A meta analysis
    • Wyatt KM, Dimmock PW, Ismail KM et al. The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis. BJOG 111(6), 585-593 (2004).
    • (2004) BJOG , vol.111 , Issue.6 , pp. 585-593
    • Wyatt, K.M.1    Dimmock, P.W.2    Ismail, K.M.3
  • 52
    • 0036252249 scopus 로고    scopus 로고
    • Assessing the assessment measures for menstrual cycle symptoms: A guide for researchers and clinicians
    • Haywood A, Slade P, King H. Assessing the assessment measures for menstrual cycle symptoms: a guide for researchers and clinicians. J. Psychosom. Res. 52(4), 223-237 (2002).
    • (2002) J. Psychosom. Res , vol.52 , Issue.4 , pp. 223-237
    • Haywood, A.1    Slade, P.2    King, H.3
  • 53
    • 0036238328 scopus 로고    scopus 로고
    • Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome
    • Feuerstein M, Shaw WS. Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome. J. Report. Med. 47(4), 279-289 (2002).
    • (2002) J. Report. Med , vol.47 , Issue.4 , pp. 279-289
    • Feuerstein, M.1    Shaw, W.S.2
  • 54
    • 0014356696 scopus 로고
    • The development of a menstrual distress questionnaire
    • Moos RH. The development of a menstrual distress questionnaire. Psychosom. Med. 30(6), 853-867 (1968).
    • (1968) Psychosom. Med , vol.30 , Issue.6 , pp. 853-867
    • Moos, R.H.1
  • 55
    • 30644476862 scopus 로고    scopus 로고
    • Daily Record of severity of problems (DRSP): Reliability and validity
    • Endicott J, Nee J, Harrison W. Daily Record of severity of problems (DRSP): reliability and validity. Arch. Womens Ment. Health 9(1), 41-49 (2006).
    • (2006) Arch. Womens Ment. Health , vol.9 , Issue.1 , pp. 41-49
    • Endicott, J.1    Nee, J.2    Harrison, W.3
  • 56
    • 34247635164 scopus 로고    scopus 로고
    • Using the daily record of severity of problems as a screening instrument for premenstrual syndrome
    • Borenstein JE, Dean BB, Yonkers KA, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. J. Obstet. Gynecol. 109(5), 1068-1075 (2007).
    • (2007) J. Obstet. Gynecol , vol.109 , Issue.5 , pp. 1068-1075
    • Borenstein, J.E.1    Dean, B.B.2    Yonkers, K.A.3    Endicott, J.4
  • 57
    • 0034671279 scopus 로고    scopus 로고
    • SF-36 health survey update
    • Ware JE Jr. SF-36 health survey update. Spine 25 (24), 3130-3139 (2000).
    • (2000) Spine , vol.25 , Issue.24 , pp. 3130-3139
    • Ware Jr., J.E.1
  • 58
    • 0017100059 scopus 로고
    • Assessment of social adjustment by patient self-report
    • Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch. Gen. Psychiatry 33(9), 1111-1115 (1976).
    • (1976) Arch. Gen. Psychiatry , vol.33 , Issue.9 , pp. 1111-1115
    • Weissman, M.M.1    Bothwell, S.2
  • 59
    • 41449111038 scopus 로고    scopus 로고
    • Development and validation of the Premenstrual Symptoms Impact Survey PMSIS, a disease-specific quality of life assessment tool
    • Wallenstein GV, Blaisdell-Gross B, Gajria K et al. Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool. J. Womens Health (Larchmt) 17(3), 439-450 (2008).
    • (2008) J. Womens Health (Larchmt , vol.17 , Issue.3 , pp. 439-450
    • Wallenstein, G.V.1    Blaisdell-Gross, B.2    Gajria, K.3
  • 60
    • 0034999148 scopus 로고    scopus 로고
    • The burden of illness of cancer: Economic cost and auality of life
    • Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and auality of life. Annu. Rev. Public Health 22, 91-113 (2001).
    • (2001) Annu. Rev. Public Health , vol.22 , pp. 91-113
    • Brown, M.L.1    Lipscomb, J.2    Snyder, C.3
  • 61
    • 0034008808 scopus 로고    scopus 로고
    • Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo
    • Pearlstein TB, Halbreich U, Batzar ED et al. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J. Clin. Psychiatry 61, 101-109 (2000).
    • (2000) J. Clin. Psychiatry , vol.61 , pp. 101-109
    • Pearlstein, T.B.1    Halbreich, U.2    Batzar, E.D.3
  • 62
    • 20044396590 scopus 로고    scopus 로고
    • Quality-of-life impairment in depressive and anxiety disorders
    • Rappaport MH. Quality-of-life impairment in depressive and anxiety disorders. Am. J. Psychiatry 162(6), 1171-1118 (2005).
    • (2005) Am. J. Psychiatry , vol.162 , Issue.6 , pp. 1171-1118
    • Rappaport, M.H.1
  • 63
    • 54349114274 scopus 로고    scopus 로고
    • Frequency, intensity and impact of premenstrual syndrome in medical students
    • Nisar N, Zehra N, Haider G et al. Frequency, intensity and impact of premenstrual syndrome in medical students. J. Coll. Physicians Surg. Pak. 18(8), 481-484 (2008).
    • (2008) J. Coll. Physicians Surg. Pak , vol.18 , Issue.8 , pp. 481-484
    • Nisar, N.1    Zehra, N.2    Haider, G.3
  • 64
    • 0032750213 scopus 로고    scopus 로고
    • The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: Experience from the United States, United Kingdom, and France
    • Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. J. Womens Health Gend. Based Med. 8(8), 1043-1052 (1999).
    • (1999) J. Womens Health Gend. Based Med , vol.8 , Issue.8 , pp. 1043-1052
    • Hylan, T.R.1    Sundell, K.2    Judge, R.3
  • 65
    • 0033819681 scopus 로고    scopus 로고
    • Premenstrual symptom severity: Impact on social functioning and treatment-seeking behaviors
    • Robinson RL, Swindle RW. Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors. J. Womens Health Gend. Based Med. 9(7), 757-768 (2000).
    • (2000) J. Womens Health Gend. Based Med , vol.9 , Issue.7 , pp. 757-768
    • Robinson, R.L.1    Swindle, R.W.2
  • 66
    • 22244472670 scopus 로고    scopus 로고
    • Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder
    • Freeman EW. Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder. Pharmacoeconomics 23(5), 433-444 (2005).
    • (2005) Pharmacoeconomics , vol.23 , Issue.5 , pp. 433-444
    • Freeman, E.W.1
  • 67
    • 0036133814 scopus 로고    scopus 로고
    • Prevalence, incidence and stability of premenstrual dysphoric disorder in the community
    • Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol. Med. 32, 119-132 (2002).
    • (2002) Psychol. Med , vol.32 , pp. 119-132
    • Wittchen, H.U.1    Becker, E.2    Lieb, R.3    Krause, P.4
  • 68
    • 3142664613 scopus 로고    scopus 로고
    • A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome
    • Dean BB, Borenstein JE. A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. J. Occup. Environ. Med. 46(7), 649-656 (2004).
    • (2004) J. Occup. Environ. Med , vol.46 , Issue.7 , pp. 649-656
    • Dean, B.B.1    Borenstein, J.E.2
  • 69
    • 12344335514 scopus 로고    scopus 로고
    • Estimating direct and indirect costs of premenstrual syndrome
    • Borenstein J, Chiou CF, Dean B et al. Estimating direct and indirect costs of premenstrual syndrome. J. Occup. Environ. Med. 47(1), 26-33 (2005).
    • (2005) J. Occup. Environ. Med , vol.47 , Issue.1 , pp. 26-33
    • Borenstein, J.1    Chiou, C.F.2    Dean, B.3
  • 71
    • 0036834438 scopus 로고    scopus 로고
    • Premenstrual dysphoric disorder: Is there an economic burden of illness?
    • Chawla A, Swindle R, Long S et al. Premenstrual dysphoric disorder: is there an economic burden of illness? Med. Care 40(11), 1101-1112 (2002).
    • (2002) Med. Care , vol.40 , Issue.11 , pp. 1101-1112
    • Chawla, A.1    Swindle, R.2    Long, S.3
  • 72
    • 35348842854 scopus 로고    scopus 로고
    • Differences in symptom scores and health outcomes in premenstrual syndrome
    • Borenstein JE, Dean BB, Leifke E et al. Differences in symptom scores and health outcomes in premenstrual syndrome. J. Womens Health (Larchmt) 16(8), 1139-1144 (2007).
    • (2007) J. Womens Health (Larchmt) , vol.16 , Issue.8 , pp. 1139-1144
    • Borenstein, J.E.1    Dean, B.B.2    Leifke, E.3
  • 74
    • 47149098016 scopus 로고    scopus 로고
    • Premenstrual dysphoric disorder: Burden of illness and treatment update
    • Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J. Psychiatry Neurosci. 33(4), 291-301 (2008).
    • (2008) J. Psychiatry Neurosci , vol.33 , Issue.4 , pp. 291-301
    • Pearlstein, T.1    Steiner, M.2
  • 75
    • 0003433982 scopus 로고
    • Murray CJL, Lopez AD Eds, Harvard University Press, MA, USA
    • The Global Burden of Disease. Murray CJL, Lopez AD (Eds). Harvard University Press, MA, USA (1966).
    • (1966) The Global Burden of Disease
  • 76
    • 38849184642 scopus 로고    scopus 로고
    • Burden of premenstrual dysphoric disorder on health-related quality of life
    • Yang M, Wallenstein G, Hagan M et al. Burden of premenstrual dysphoric disorder on health-related quality of life. J. Womens Health (Larchmt) 17(1), 113-121 (2008).
    • (2008) J. Womens Health (Larchmt) , vol.17 , Issue.1 , pp. 113-121
    • Yang, M.1    Wallenstein, G.2    Hagan, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.